Read more

May 24, 2024
1 min read
Save

Top in allergy/asthma: Allergen immunotherapy may prevent asthma; EHR prompts beneficial

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Patients who received subcutaneous allergen immunotherapy for house dust mite had a reduced probability of asthma onset and development of asthma from allergic rhinitis over time, according to a recent study.

Researchers recruited patients aged 5 to 70 years who had house dust mite allergy to participate in the study. Compared with a control group of patients who did not receive allergen immunotherapy, those in the subcutaneous immunotherapy group had reduced mean asthma prescriptions and allergic rhinitis prescriptions. It was the top story in allergy/asthma last week.

House dust mite
Patients who received subcutaneous allergen immunotherapy for house dust mite had a reduced probability of asthma onset and development of asthma from allergic rhinitis over time, according to a recent study. Image: Adobe Stock

In another top story, researchers found that electronic health record prompts increased the use of guideline-based preventive asthma care for children in pediatric and family practice clinics.

Read these and more top stories in allergy/asthma below:

Subcutaneous allergen immunotherapy reduces asthma risk, improves symptom control

Subcutaneous allergen immunotherapy for house dust mite reduced the number of prescriptions for allergic rhinitis and asthma medications, according to a study published in The European Journal of Allergy and Clinical Immunology. Read more.

Prompts in electronic health records improve guideline-based asthma care

Prompts in electronic health records increased the use of guideline-based preventive asthma care for children, according to a study presented at the Pediatric Academic Societies Meeting. Read more.

FDA grants priority review to dupilumab for adolescents with CRSwNP

The FDA has accepted for priority review the supplemental biologics license application of dupilumab for adolescents with chronic rhinosinusitis with nasal polyps, Regeneron Pharmaceuticals Inc. and Sanofi announced in a press release. Read more.

Global food environments affect asthma disease burden

Macronutrient supply and socioeconomic status are emerging confounding variables for asthma, according to an analysis published in The European Journal of Allergy and Clinical Immunology. Read more.

Impulse oscillometry may predict asthma, impaired lung function in children

Increased respiratory resistance in preschool children is associated with respiratory symptoms and the onset of childhood asthma, according to a study published in The Journal of Allergy and Clinical Immunology. Read more.